EP Patent

EP2985038A1 — Lyophilized API preparation

Assigned to Azad Pharma AG · Expires 2016-02-17 · 10y expired

What this patent protects

The present invention relates to lyophilized preparations comprising an active pharmaceutical ingredient (API) for pharmaceutical use as well as methods of preparing same.

USPTO Abstract

The present invention relates to lyophilized preparations comprising an active pharmaceutical ingredient (API) for pharmaceutical use as well as methods of preparing same.

Drugs covered by this patent

bendamustine-hydrochloride (BENDAMUSTINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP2985038A1
Jurisdiction: EP
Classification: —
Expires: 2016-02-17
Drug substance claim: No
Drug product claim: No
Assignee: Azad Pharma AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.